Tetra-O-Methyl Nordihydroguaiaretic Acid Induces Growth Arrest and Cellular Apoptosis by Inhibiting Cdc2 and Survivin Expression
We previously reported that Sp1-dependent Cdc2 gene expression is inhibited by tetra-O-methyl nordihydroguaiaretic acid ( M4 N) and that M4 N is likely responsible for causing growth arrest in M4 N-treated transformed C3 cells. Here, we show that after M4 N treatment and cell-cycle arrest, expressio...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 101; no. 36; pp. 13239 - 13244 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
National Academy of Sciences
07-09-2004
National Acad Sciences |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We previously reported that Sp1-dependent Cdc2 gene expression is inhibited by tetra-O-methyl nordihydroguaiaretic acid ( M4 N) and that M4 N is likely responsible for causing growth arrest in M4 N-treated transformed C3 cells. Here, we show that after M4 N treatment and cell-cycle arrest, expression of the Sp1-dependent survivin gene, a member of the inhibitor of apoptosis family, is also suppressed, and the mitochondrial apoptotic pathway is activated. To confirm that inhibition of Cdc2 and survivin gene expression is necessary for M4 N-induced growth arrest and apoptosis, we tested the effect of adding Cdc2 and survivin back to M4 N-treated cells. Cell division was transiently restored in the presence of M4 N after transfection of an exogenous Cdc2 gene copy under the control of the Sp1-independent cytomegalovirus promoter. Caspase-3 activation was also reduced by 50% and 75% in transiently and stably survivin-transfected C3 cells, respectively. The results suggest that M4 N induces growth arrest and apoptosis by suppressing Cdc2 and survivin expression, which constitutes the cellular basis of its antitumoric action. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Erimos Pharmaceuticals, LLC, Suite 170, 940 Main Campus Drive, Raleigh, NC 27606. Communicated by Saul Roseman, The Johns Hopkins University, Baltimore, MD, July 26, 2004 To whom correspondence should be addressed. E-mail: rhuang@jhu.edu. Abbreviations: M4N, tetra-O-methyl nordihydroguaiaretic acid; CMV, cytomegalovirus. Present address: Department of Medicine, Columbia University, New York, NY 10032. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0405407101 |